Accelerated evolution of resistance in multidrug environments
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The emergence of resistance during multidrug chemotherapy impedes the treatment of many human diseases, including malaria, TB, HIV, and cancer. Although certain combination therapies have long been known to be more effective in curing patients than single drugs, the impact of such treatments on the evolution of drug resistance is unclear. In particular, very little is known about how the evolution of resistance is affected by the nature of the interactions—synergy or antagonism—between drugs. Here we directly measure the effect of various inhibitory and subinhibitory drug combinations on the rate of adaptation. We develop an automated assay for monitoring the parallel evolution of hundreds of Escherchia coli populations in a two-dimensional grid of drug gradients over many generations. We find a correlation between synergy and the rate of adaptation, whereby evolution in more synergistic drug combinations, typically preferred in clinical settings, is faster than evolution in antagonistic combinations. We also find that resistance to some synergistic combinations evolves faster than resistance to individual drugs. The accelerated evolution may be due to a larger selective advantage for resistance mutations in synergistic treatments. We describe a simple geometric model in which mutations conferring resistance to one drug of a synergistic pair prevent not only the inhibitory effect of that drug but also its enhancing effect on the other drug. Future study of the profound impact that synergy and other drug-pair properties can have on the rate of adaptation may suggest new treatment strategies for combating the spread of antibiotic resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the interactions can be highly dosedependent”
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 2×
“To experimentally explore the relation between drug interaction and the rate of adaptation, we compared a drug pair that exhibits strong antagonism [doxycycline (DOX), a tetracycline antibiotic, and ciprofloxacin (CIP), a fluoroquinolone] to another pair showing strong synergy [DOX and a macrolide antibiotic, erythrom…”
BackgroundAntibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins
Weinreich, D. M., Delaney, N. F., DePristo, M. A., & Hartl, D. L. (2006) · Science · doi:10.1126/science.1123539 · Cited by 1,415
Self-citationBerenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Evolution Experiments with Microorganisms: The Dynamics and Genetic Bases of Adaptation
Elena, S. F., & Lenski, R. E. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1088 · Cited by 1,386
Antibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
Lack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby, S. R., Nord, C. E., & Finch, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01283-1 · Cited by 491
Research works printed but not linked: 1
- 10.1016/s1473-3099(05)70086-4 · doi:10.1016/s1473-3099(05)70086-4 · Paper page
Cited by
Items 101–200 of 341
Wambaugh, M. A., Shakya, V. P. S., Lewis, A. J., Mulvey, M. A., & Brown, J. C. S. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001644 · Cited by 63
Sánchez−Osuna, M., Cortés, P., Llagostera, M., Barbé, J., & Erill, I. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000440 · Cited by 62
Uncovering Scaling Laws to Infer Multidrug Response of Resistant Microbes and Cancer Cells
Wood, K. B., Wood, K. C., Nishida, S., & Cluzel, P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.007 · Cited by 61
Pervasive selection for and against antibiotic resistance in inhomogeneous multistress environments
Chait, R., Palmer, A. C., Yelin, I., & Kishony, R. (2016) · Nature Communications · doi:10.1038/ncomms10333 · Cited by 61
Self-citationEmergence and natural selection of drug-resistant prions
Shorter, J. (2010) · Molecular BioSystems · doi:10.1039/c004550k · Cited by 60
Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum
Ankomah, P., & Levin, B. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002487 · Cited by 60
Wang, D., Ning, Q. X., Deng, Z., Zhang, M., & You, J. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119603 · Cited by 58
Evolutionary ecology meets the antibiotic crisis
Roemhild, R., & Schulenburg, H. (2019) · Evolution Medicine and Public Health · doi:10.1093/emph/eoz008 · Cited by 58
Dong, C., Zhou, J., Wang, P., Li, T., Zhao, Y. H., Ren, X., Lu, J., Wang, J., Holmgren, A., & Zou, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03016 · Cited by 58
Laehnemann, D., Peña‐Miller, R., Rosenstiel, P. C., Beardmore, R., Jansen, G., & Schulenburg, H. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu106 · Cited by 58
Studies on the antibiotic susceptibility of Escherichia coli
Luidalepp, H. (2012) · DSpace repository (University of Tartu) · Cited by 58
Uncovering emergent interactions in three-way combinations of stressors
Beppler, C., Tekin, E., Mao, Z., White, C., McDiarmid, C., Vargas, E. A., Miller, J. H., Savage, V. M., & Yeh, P. J. (2016) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0800 · Cited by 56
Ankomah, P., Johnson, P. J., & Levin, B. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003300 · Cited by 54
Evolutionary epidemiology 20 years on: Challenges and prospects
Restif, O. (2008) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2008.09.007 · Cited by 52
Wood, K. B., & Cluzel, P. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-48 · Cited by 51
Smart Food Waste Recycling Bin (S-FRB) to turn food waste into green energy resources
Yeo, J., Oh, J.-I., Cheung, H. H. L., Lee, P. K. H., & An, A. K. (2019) · Journal of Environmental Management · doi:10.1016/j.jenvman.2018.12.088 · Cited by 51
Eger, E., Schwabe, M., Schulig, L., Hübner, N., Bohnert, J. A., Bornscheuer, U. T., Heiden, S. E., Müller, J. U., Adnan, F., Becker, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00148-22 · Cited by 50
Extreme Antibiotic Persistence via Heterogeneity-Generating Mutations Targeting Translation
Khare, A., & Tavazoie, S. (2020) · mSystems · doi:10.1128/msystems.00847-19 · Cited by 51
Mutators can drive the evolution of multi-resistance to antibiotics
Gifford, D. R., Berríos-Caro, E., Joerres, C., Suñé, M., Forsyth, J. H., Bhattacharyya, A., Galla, T., & Cg, K. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010791 · Cited by 48
Ultra-Small Silver Nanoparticles: A Sustainable Green Synthesis Approach for Antibacterial Activity
Castañeda-Aude, J. E., Morones‐Ramírez, J. R., Río, D. A. D. H. D., León‐Buitimea, A., Barriga‐Castro, E. D., & Escárcega‐González, C. E. (2023) · Antibiotics · doi:10.3390/antibiotics12030574 · Cited by 46
Morici, P., Florio, W., Rizzato, C., Ghelardi, E., Tavanti, A., Rossolini, G. M., & Lupetti, A. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2987-7 · Cited by 45
Jangir, P. K., Ogunlana, L., & MacLean, R. C. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.007 · Cited by 45
Bacterial responses to antibiotics and their combinations
Mitosch, K., & Bollenbach, T. (2014) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12190 · Cited by 44
Sahu, M. C., Debata, N. K., & Padhy, R. N. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60316-5 · Cited by 44
Antibiotic interactions shape short-term evolution of resistance in E. faecalis
Dean, Z., Maltas, J., & Wood, K. B. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008278 · Cited by 43
Lindström, H. J. G., & Friedman, R. (2020) · BMC Cancer · doi:10.1186/s12885-020-06782-9 · Cited by 43
Toward a quantitative understanding of antibiotic resistance evolution
Lukačišinová, M., & Bollenbach, T. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.02.013 · Cited by 41
Ma, X., Xi, W., Yang, D., Zhao, L., Yu, W., He, Y., Ni, W., & Gao, Z. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100961 · Cited by 41
Improved network performance via antagonism: From synthetic rescues to multi‐drug combinations
Motter, A. E. (2010) · BioEssays · doi:10.1002/bies.200900128 · Cited by 39
Gjini, E., & Wood, K. B. (2021) · eLife · doi:10.7554/elife.64851 · Cited by 39
Acceleration and suppression of resistance development by antibiotic combinations
Suzuki, S., Horinouchi, T., & Furusawa, C. (2017) · BMC Genomics · doi:10.1186/s12864-017-3718-2 · Cited by 39
Identifying and Tackling Emergent Vulnerability in Drug-Resistant Mycobacteria
Padiadpu, J., Baloni, P., Anand, K., Munshi, M., Thakur, C., Mohan, A., Singh, A., & Chandra, N. R. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00004 · Cited by 39
Pajares‐Chamorro, N., Shook, J. C., Hammer, N. D., & Chatzistavrou, X. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.012 · Cited by 38
Soares, J. M., Corrêa, T. Q., Patiño, C. P. B., Gonçalves, I. S., dos Santos, G. G., Guimarães, G. G., de Lima, R. V., Lima, T. H. N., Corrêa, B. C., Cappellini, T. C. D. S., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00369 · Cited by 38
Cisneros-Mayoral, S., Graña-Miraglia, L., Pérez‐Morales, D., Peña‐Miller, R., & Fuentes-Hernández, A. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac185 · Cited by 38
THE EVOLUTIONARY EPIDEMIOLOGY OF MULTILOCUS DRUG RESISTANCE
Day, T., & Gandon, S. (2012) · Evolution · doi:10.1111/j.1558-5646.2011.01533.x · Cited by 38
Measuring higher-order drug interactions: A review of recent approaches
Tekin, E., Savage, V. M., & Yeh, P. J. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.015 · Cited by 38
Jahn, L. J., Simon, D., Jensen, M., Bradshaw, C., Ellabaan, M. M. H., & Sommer, M. O. A. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab006 · Cited by 38
Statistical questions in experimental evolution
Desai, M. M. (2013) · Journal of Statistical Mechanics Theory and Experiment · doi:10.1088/1742-5468/2013/01/p01003 · Cited by 36
When more is less: Emergent suppressive interactions in three-drug combinations
Beppler, C., Tekin, E., White, C., Mao, Z., Miller, J. H., Damoiseaux, R. D., Savage, V. M., & Yeh, P. J. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1017-3 · Cited by 36
Beta-lactamase dependent and independent evolutionary paths to high-level ampicillin resistance
Gross, R., Yelin, I., Lázár, V., Datta, M. S., & Kishony, R. (2024) · Nature Communications · doi:10.1038/s41467-024-49621-2 · Cited by 35
Self-citationLagomarsino, M. C., Espéli, O., & Junier, I. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.002 · Cited by 34
Zhao, N., Fan, W., Zhao, X., Liu, Y., Hu, Y., Duan, F., & Xu, F. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22373 · Cited by 34
Facile construction of polycation/Au@CuS nanohybrids for synergistic gene/photothermal therapy
Zheng, D., Zhao, X., Wang, Y., Dai, X., Guo, K., Xu, C., Zhao, N., & Xu, F. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.150271 · Cited by 33
Dai, X., Liu, Z., Zhao, X., Guo, K., Ding, X., Xu, F., & Zhao, N. (2024) · Advanced Materials · doi:10.1002/adma.202407927 · Cited by 32
First steps in experimental cancer evolution
Taylor, T., Johnson, L. J., Jackson, R. W., Brockhurst, M. A., & Dash, P. R. (2013) · Evolutionary Applications · doi:10.1111/eva.12041 · Cited by 32
Development of antibacterial compounds that constrain evolutionary pathways to resistance
Zhang, Y., Chowdhury, S., Rodrigues, J. V., & Shakhnovich, E. I. (2021) · eLife · doi:10.7554/elife.64518 · Cited by 32
Prevalent Synergy and Antagonism Among Antibiotics and Biocides in Pseudomonas aeruginosa
Pietsch, F., Heidrich, G., Nordholt, N., & Schreiber, F. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.615618 · Cited by 32
Optimizing antimicrobial prescribing
Istúriz, R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(10)70006-6 · Cited by 31
Worthan, S. B., McCarthy, R. D. P., & Behringer, M. G. (2023) · Journal of Molecular Evolution · doi:10.1007/s00239-022-10087-9 · Cited by 31
Zeng, Q., Tian, X., & Wang, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-17640-3 · Cited by 31
Drug dependence in cancer is exploitable by optimally constructed treatment holidays
Maltas, J., Killarney, S. T., Singleton, K. R., Strobl, M. A. R., Washart, R., Wood, K. C., & Wood, K. B. (2023) · Nature Ecology & Evolution · doi:10.1038/s41559-023-02255-x · Cited by 32
Shao, N., Yuan, L., Liu, L., Cong, Z., Wang, J., Wu, Y., & Liu, R. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c00434 · Cited by 30
Ouyang, Y., Tang, X., Zhao, Y. H., Zuo, X., Ren, X., Wang, J., Zou, L., & Lu, J. (2023) · Antioxidants · doi:10.3390/antiox12061180 · Cited by 30
Garza-Cervantes, J. A., Meza-Bustillos, J. F., Resendiz-Hernández, H., Suárez-Cantú, I. A., Ortega-Rivera, O. A., Salinas, E., Escárcega‐González, C. E., & Morones‐Ramírez, J. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00612 · Cited by 30
Lateral transfer and GC content of bacterial resistant genes
Hayek, N. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00041 · Cited by 30
The use of bacteriophages as One-Health approach to reduce multidrug-resistant bacteria
Kittler, S., Wittmann, J., Mengden, R., Klein, G., Rohde, C., & Lehnherr, H. (2016) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2016.06.001 · Cited by 30
Genomic evolution of bacterial populations under coselection by antibiotics and phage
Cairns, J., Frickel, J., Jalasvuori, M., Hiltunen, T., & Becks, L. (2017) · Molecular Ecology · doi:10.1111/mec.13950 · Cited by 29
A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway
Wang, K. K., Stone, L. K., Lieberman, T. D., Shavit, M., Baasov, T., & Kishony, R. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv243 · Cited by 29
Self-citationLiu, Y., Dai, X., Yu, B., Chen, M., Zhao, N., & Xu, F. (2022) · Biomaterials Science · doi:10.1039/d2bm00296e · Cited by 28
Wang, Y., He, M., Miron, R. J., Chen, A., Zhao, Y., & Zhang, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10384 · Cited by 27
Modification ofEscherichia coli–bacteriophage interactions by surfactants and antibioticsin vitro
Scanlan, P. D., Bischofberger, A. M., & Hall, A. R. (2016) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiw211 · Cited by 27
Hallinen, K. M., Karslake, J., & Wood, K. B. (2020) · eLife · doi:10.7554/elife.52813 · Cited by 27
Ng, K., Alygizakis, ., Τhomaidis, Ν. S., & Slobodník, J. (2023) · Antibiotics · doi:10.3390/antibiotics12010100 · Cited by 27
The optimal deployment of synergistic antibiotics: a control-theoretic approach
Peña‐Miller, R., Laehnemann, D., Schulenburg, H., Ackermann, M., & Beardmore, R. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0279 · Cited by 26
Eller, K. A., Aunins, T. R., Courtney, C. M., Campos, J. K., Otoupal, P. B., Erickson, K. E., Madinger, N. E., & Chatterjee, A. (2021) · Communications Biology · doi:10.1038/s42003-021-01856-1 · Cited by 26
Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer
Yadav, S. S., Li, J., Stockert, J. A., O’Connor, J., Herzog, B. J., Elaiho, C. R., Galsky, M. D., Tewari, A. K., & Yadav, K. K. (2016) · Oncotarget · doi:10.18632/oncotarget.12771 · Cited by 25
Pairwise interactions and the battle against combinatorics in multidrug therapies
Wood, K. B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612365113 · Cited by 25
The Genomic Basis of Rapid Adaptation to Antibiotic Combination Therapy in Pseudomonas aeruginosa
Barbosa, C., Mahrt, N., Bunk, J., Graßer, M., Rosenstiel, P. C., Jansen, G., & Schulenburg, H. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa233 · Cited by 25
Fighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs
Cansizoglu, M. F., & Toprak, E. (2017) · Current Genetics · doi:10.1007/s00294-017-0703-x · Cited by 24
Dai, C., Liu, Y., Lv, F., Cheng, P., & Qu, S. (2025) · Advanced Biotechnology · doi:10.1007/s44307-025-00059-7 · Cited by 24
Potentiating antibiotic efficacy via perturbation of non-essential gene expression
Otoupal, P. B., Eller, K. A., Erickson, K. E., Campos, J. K., Aunins, T. R., & Chatterjee, A. (2021) · Communications Biology · doi:10.1038/s42003-021-02783-x · Cited by 24
Sinha, D. K., Pandey, S., Singh, R., Tiwari, V., Sad, K., & Tandon, V. (2017) · Scientific Reports · doi:10.1038/srep44419 · Cited by 24
Lee, Y. H., & Helmann, J. D. (2014) · Journal of Bacteriology · doi:10.1128/jb.02022-14 · Cited by 24
Sequential antibiotic therapy in the laboratory and in the patient
Nyhoegen, C., & Uecker, H. (2023) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0793 · Cited by 24
Maltas, J., Tadele, D. S., Durmaz, A., McFarland, C. D., Hinczewski, M., & Scott, J. G. (2024) · PRX Life · doi:10.1103/prxlife.2.023010 · Cited by 23
Ross, L. S., Lafuente-Monasterio, M. J., Sakata, T., Mandt, R. E. K., Gamo, F., Wirth, D. F., & Lukens, A. K. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00217 · Cited by 23
Kelly, P., Hadi-Nezhad, F., Liu, D. Y., Lawrence, T. J., Linington, R. G., Ibba, M., & Ardell, D. H. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007983 · Cited by 23
The many dimensions of combination therapy: How to combine antibiotics to limit resistance evolution
Nyhoegen, C., Bonhoeffer, S., & Uecker, H. (2024) · Evolutionary Applications · doi:10.1111/eva.13764 · Cited by 22
Witzany, C., Rolff, J., Regoes, R. R., & Igler, C. (2023) · Microbiology · doi:10.1099/mic.0.001368 · Cited by 23
Resource Competition May Lead to Effective Treatment of Antibiotic Resistant Infections
Gomes, A. L. C., Galagan, J. E., & Segrè, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080775 · Cited by 22
Sulaiman, J. E., Long, L., Wu, L., Qian, P., & Lam, H. (2021) · iScience · doi:10.1016/j.isci.2021.102950 · Cited by 22
A flexible bowl-shaped magnetic assembly for multifunctional gene delivery systems
Wang, R., Dai, X., Duan, S., Zhao, N., & Xu, F. (2019) · Nanoscale · doi:10.1039/c9nr04763h · Cited by 22
Zhou, Z., Li, J., Tan, L., Liu, X., Zheng, Y., Cui, Z., Li, C., Yeung, K., Li, Z., Liang, Y., et al. (2021) · Fundamental Research · doi:10.1016/j.fmre.2021.11.019 · Cited by 21
Role of synergy and antagonism in designing multidrug adaptive chemotherapy schedules
Newton, P. K., & Ma, Y. (2021) · Physical review. E · doi:10.1103/physreve.103.032408 · Cited by 21
The immune system of maggots of the blow fly (Calliphora vicina) as a source of medicinal drugs
Chernysh, S. I., & Gordya, N. A. (2011) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093011060032 · Cited by 21
Lethal Effect of Photodynamic Treatment on Persister Bacteria
Oppezzo, O. J., & Giacobone, A. F. F. (2017) · Photochemistry and Photobiology · doi:10.1111/php.12843 · Cited by 21
Chen, D., Lei, C., Liu, W., Shao, M., Sun, M., Guo, J., Cao, J., Nie, J., Luo, P., Luo, Y., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.05.012 · Cited by 21
Sun, D. S., Dalin, S., Hemann, M. T., Lauffenburger, D. A., & Zhao, B. (2016) · Scientific Reports · doi:10.1038/srep36198 · Cited by 20
Nguyen, C., Zhou, A. L., Khan, A., Miller, J. H., & Yeh, P. J. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.26 · Cited by 19
Peña‐Miller, R., Laehnemann, D., Schulenburg, H., Ackermann, M., & Beardmore, R. (2011) · Bulletin of Mathematical Biology · doi:10.1007/s11538-011-9698-5 · Cited by 19
Campbell, E. M., & Chao, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086971 · Cited by 18
An ecosystem framework for understanding and treating disease
Hochberg, M. (2018) · Evolution Medicine and Public Health · doi:10.1093/emph/eoy032 · Cited by 17
Climate warming promotes collateral antibiotic resistance development in cyanobacteria
Wang, Z., Chen, Q., Zhang, J., Xu, H., Miao, L., Zhang, T., Liu, D., Zhu, Q., Yan, H., & Yan, D. (2024) · Water Research · doi:10.1016/j.watres.2024.121642 · Cited by 17
Poostforooshan, J., Belbekhouche, S., Olszok, V., Stodt, M. F. B., Simmler, M., Bierwirth, M., Nirschl, H., Kiefer, J., Fritsching, U., & Weber, A. P. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c03107 · Cited by 17
Bleackley, M. R., Dawson, C. S., McKenna, J. A., Quimbar, P., Hayes, B. M. E., van der Weerden, N. L., & Anderson, M. A. (2017) · mSphere · doi:10.1128/msphere.00390-17 · Cited by 17
Phenotypically heterogeneous populations in spatially heterogeneous environments
Patra, P., & Klumpp, S. (2014) · Physical Review E · doi:10.1103/physreve.89.030702 · Cited by 17
Synergistic Synthetic Biology: Units in Concert
Trosset, J., & Carbonell, P. (2013) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2013.00011 · Cited by 16
Synergistic Drug Combinations Promote the Development of Resistance in Acute Myeloid Leukemia
Mason‐Osann, E., Pomeroy, A. E., Palmer, A. C., & Mettetal, J. T. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0067 · Cited by 16
Modeling spatial evolution of multi-drug resistance under drug environmental gradients
Freire, T., Hu, Z., Wood, K. B., & Gjini, E. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012098 · Cited by 16
Metadata
- Authors
- Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R.
- Affiliations
- Harvard University (US)
- *Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115;
- Vertex Pharmaceuticals (United States) (US)
- Department of Organismic and Evolutionary Biology and
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-16
- Volume
- 105
- Issue
- 37
- Pages
- 13977-13981
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2544564
- OpenAlex
- W2080777238
- Cited by
- 300
- References
- 33
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 12 · 2021: 21 · 2020: 18 · 2019: 20 · 2018: 12 · 2017: 28 · 2016: 18 · 2015: 21 · 2014: 18 · 2013: 21 · 2012: 7
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM081617)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- drug resistance evolution, multidrug chemotherapy, drug synergy, drug antagonism, combination therapy, rate of adaptation, Escherichia coli, parallel evolution, antibiotic resistance, resistance mutations
- MeSH terms
- Adaptation, Biological, Biological Evolution, Drug Resistance, Multiple
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.